Proteotype Awarded £1.5 Million Grant to Advance Early Cancer Detection with Innovative Enlighten® Test
07.08.2025 - 18:08:24
is a pioneering diagnostics company dedicated to the development of advanced multi-cancer early detection and personalised medicine tests that measure the host response to tumour development. By leveraging cutting-edge technologies and comprehensive research, Proteotype aims to revolutionise cancer diagnostics and improve early detection, ultimately enhancing patient outcomes and survival rates.
Media contact: pr@proteotype.com
Email invest@proteotype.com to partner and bring this test to a clinic near you.
Photo - https://mma.prnewswire.com/media/2526337/Proteotype_Diagnostics_Co_founders.jpg
Logo - https://mma.prnewswire.com/media/2526336/Proteotype_Diagnostics_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/proteotype-awarded-1-5-million-grant-to-advance-early-cancer-detection-with-innovative-enlighten-test-302271640.html
